News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Celgene Corporation Reviews 2009 Achievements and Announces 2010 Financial Outlook
January 11, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) 2009 Fourth Quarter Financial Results Year-Over-Year (Unaudited).
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Earnings
Pfizer flat in Q3 despite 32% growth for new and acquired products
November 3, 2026
·
2 min read
·
Annalee Armstrong
Business
Karyopharm files for bankruptcy, looks to merger with Ayrmid for life raft
November 2, 2026
·
3 min read
·
Angela Gabriel
Manufacturing
Sun Pharma stops eye-care drug production at Indian plant amid quality issues
November 2, 2026
·
2 min read
·
Nick Paul Taylor
Multiple sclerosis
Tiziana touts multiple sclerosis win at lower dose as high dose misses mark
November 2, 2026
·
2 min read
·
Gabrielle Masson
